Société des Industries Pharmaceutiques de Tunisie - S.A. Stock

Equities

SIPHA

TN0006670012

Pharmaceuticals

End-of-day quote Tunis 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
3.92 TND +4.53% Intraday chart for Société des Industries Pharmaceutiques de Tunisie - S.A. +4.53% +4.26%
Sales 2021 * 9.51M 3.03M Sales 2022 * - Capitalization 7.06M 2.25M
Net income 2021 * -22M -7.01M Net income 2022 * - EV / Sales 2021 * 7.11 x
Net Debt 2021 * 60.6M 19.31M Net cash position 2022 * - 0 EV / Sales 2022 * -
P/E ratio 2021 *
-0.32 x
P/E ratio 2022 *
-
Employees -
Yield 2021 *
-
Yield 2022 *
-
Free-Float 20.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.53%
1 week+4.53%
Current month+4.53%
1 month+4.53%
3 months+4.26%
6 months-38.75%
Current year+4.26%
More quotes
1 week
3.92
Extreme 3.92
3.92
1 month
3.92
Extreme 3.92
3.92
Current year
3.75
Extreme 3.75
3.93
1 year
3.50
Extreme 3.5
6.40
3 years
3.20
Extreme 3.2
6.40
5 years
2.36
Extreme 2.36
6.40
10 years
2.36
Extreme 2.36
10.59
More quotes
Managers TitleAgeSince
Chief Executive Officer - 17-08-18
Comptroller/Controller/Auditor - -
Members of the board TitleAgeSince
Chief Executive Officer - 17-08-18
Director/Board Member - 18-12-31
Director/Board Member - 18-12-31
More insiders
Date Price Change Volume

End-of-day quote Tunis, April 18, 2024

More quotes
Société des Industries Pharmaceutiques de Tunisie (SIPHAT) specializes in manufacturing and marketing pharmaceutical products. Net sales break down by source of income as follows: - sales to hospitals (52.1%); - sales to consumer (43.8%); The remaining net sales (4.1%) are from the overseas sale activity.
More about the company
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
3.92 TND
Average target price
0.28 TND
Spread / Average Target
-92.86%
Consensus